Clinical Trial Update: Adebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating adebrelimab with or without induction chemotherapy followed by concurrent chemoradiotherapy for unresectable locally advanced …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Adebrelimab (adebrelimab)

Snippet

Sponsor: Fujian Medical University Union Hospital | Conditions: Esophageal Squamous Cell Carcinoma, Immunotherapy | Phase 2 | Status: RECRUITING